Three independent discounted-cash-flow-style models value CVS HEALTH CORPORATION every trading day. 2 of 3 currently price CVS above its market price.
| Free Cash Flow model | $575.46 |
| Excess Profit model | $445.16 |
| Residual Earnings model | $36.36 |
| Dividend Discount model | $153.26 |
| Piotroski F-Score | 7 / 9 |
| Return on invested capital | +6.4% |
| Net debt / EBITDA | 6.2× |
| Gross margin | +39.3% |
| Revenue CAGR | +10.0% |
| Cash conversion | 1.6× |
| Dividend yield | +3.8% |
| Buyback yield | +2.1% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open CVS in StockKitty